Advent International has agreed to acquire a majority stake in Salt & Stone, the Los Angeles-based body care brand known for its high-performance formulations and retail presence across Sephora, REI, and Net-a-Porter.
The deal follows a pattern. In the past 18 months, Corpus has raised institutional capital, Nécessaire has grown into a multi-category brand with serious retail footprint, and several other body care brands have either been acquired or completed significant funding rounds. The category is attracting capital at a rate that did not exist three years ago.
Understanding why tells you something about where the overall beauty market is heading.
Why body care now
There are four structural reasons body care is attracting institutional investment at this moment.
The formulation upgrade runway is long. Body care has historically been treated as a commodity category. Moisturisers, body washes, and SPF products have largely competed on price and fragrance rather than active ingredients. That is starting to change as the consumer who has been educated on skincare actives starts asking why their body moisturiser does not have the same formulation logic as their face cream. The gap between what the best face product delivers and what the average body product delivers is enormous. That gap is a commercial opportunity for brands willing to close it.
The repeat purchase mechanics are excellent. Body care products are used on a much larger surface area than face products. They are consumed faster. The repeat purchase cycle for a body lotion or body wash is typically four to eight weeks, compared to three to six months for many face treatments. Fast repeat purchase cycles with viable margins create the cohort revenue that institutional investors find compelling.
The margin profile is workable. Premium body care brands are selling body oils, exfoliants, and treatment lotions at £20 to £45. The cost of goods at those formulation standards, at reasonable production volume, produces margins that support a sustainable business. It is not as margin-rich as fragrance or colour cosmetics, but it is materially better than commoditised mass body care.
The category leader position is still open. There is not yet a default premium body care brand with the kind of retail presence that Tatcha or La Mer has in face skincare. The shelf space exists, the consumer demand exists, but the category is still fragmented. The brand that establishes itself as the category reference in premium body care over the next three years will be extremely valuable.
What Salt & Stone specifically brought to the deal
Salt & Stone built a product line that positioned body care as a performance category. Their UV Defence Body Lotion, deodorant formulations, and recovery-focused body care products speak a functional language borrowed from sport and wellness.
Their retail footprint spans prestige beauty (Sephora), outdoor and lifestyle (REI), and fashion-forward e-commerce (Net-a-Porter). That multi-channel credibility is difficult to build and very attractive to an acquirer who wants to scale distribution without rebuilding trust from scratch.
The combination of formulation credibility and channel diversification is what made Salt & Stone acquirable at a meaningful multiple. Brands that have one without the other tend to get acquired at lower valuations, or not at all.
What this means for other body care brands
The Advent and Salt & Stone deal establishes a benchmark. Institutional capital is now actively interested in premium body care. The question for founders in the space is whether they are building businesses that meet the criteria investors are using.
Those criteria are fairly consistent: a proven formulation story with some clinical or functional evidence, a repeat purchase rate above 40% at 12 months, gross margins above 55%, a channel mix that is not entirely dependent on one retailer or on DTC alone, and a customer base that skews to consumers who have already been educated on skincare.
Brands that are building toward those metrics now will have optionality. They can raise capital, attract a strategic acquirer, or build a sustainably profitable business without either. All three of those outcomes are better than the alternative.
The body care category is where skincare was in 2016. The brands that move with clarity and intention over the next three years will be the ones private equity is competing to acquire in 2028 and 2029.
The window is open. It will not stay open at the same cost for long.